Evonik Tegin Pellets Ep - Tds
Evonik Tegin Pellets Ep - Tds
TEGIN® Pellets
INCI (PCPC name) Oil phase including the emulsifier and water phase
are heated separately to 65 °C.
Glyceryl Stearate SE
Evonik Nutrition & Care GmbH | TEGIN® Pellets | May 2008 Page 1/3
Homogenization below 50 °C has a negative Guideline formulations
influence on the consistency promoting gel
O/W Care Cream - ECOCERT conform –
structures.
F 26/97
Phase A
Influence of the degree of dispersion on emulsion
quality TEGIN® Pellets 8.0%
Stearic Acid 2.0%
Coarsely dispersed emulsions appear dull and
slightly inhomogeneous. Extremely small diameters TEGOSOFT® CT 14.0%
for the present have a positive influence on the (Caprylic/Capric Triglyceride)
appearance of the creams (creams look "brilliant"), Avocado (Persea Gratissima) Oil 10.0%
but they promote gradual formation of Tocopheryl Acetate 0.9%
inhomogeneous structures ("gritty" creams), which
Retinyl Palmitate 0.1%
become visible after days or weeks. These
Phase B
inhomogeneous structures are due to partial changes
in the consistency promoting crystal structures. The Glycerin 2.0%
latter are based on glycerol monodistearate and are Water 63.0%
stabilized by the hydrophilic potassium stearate. Phase Z
Reason for the negative influence of intensive
Preservative, Perfume q.s.
homogenisation presumably is: With increasing
Preparation:
degree of dispersion a higher amount of potassium
stearate is absorbed in the interface. This means that 1. Heat phase A and B separately to approx.
the portion available for building up the consistency- 70 - 75 °C.
promoting gel structures decreases below 2. Add phase A to phase B with stirring. 1)
the minimal dosage required for long-term stability. 3. Homogenize.
Average particle sizes of approx. 5 µm are optimal. 4. Cool with gentle stirring.
Packaging
Information concerning
Evonik Nutrition & Care GmbH | TEGIN® Pellets | May 2008 Page
2/3
O/W Hand Care Treatment O/W Natural Foot Care Balm
GP 4/99-11 F 34/01-4
Phase A Phase A
TEGIN® Pellets 6.0% TEGIN® Pellets 6.0%
TEGO® Alkanol 1618 2.0% TEGO® Alkanol 18 1.0%
(Cetearyl Alcohol) (Stearyl Alcohol)
Stearic Acid 2.0% Stearic Acid 2.0%
TEGOSOFT® OS 3.0% TEGOSOFT® liquid 4.0%
(Ethylhexyl Stearate) (Cetearyl Ethylhexanoate)
Mineral Oil (30 mPas) 3.0% TEGOSOFT® HP 3.0%
ABIL® 350 (Dimethicone) 1.5% (Isocetyl Palmitate)
Preparation: Phase Z
1) Important information:
If phase A has to be charged into the vessel first,
phase B must be added without stirring.
E 05/08
This information and all further technical advice is based on our present knowledge and experience. However, it implies no liability or
other legal responsibility on our part, including with regard to existing third party intellectual property rights, especially patent rights. In
particular, no warranty, whether express or implied, or guarantee of product properties in the legal sense is intended or implied. We
reserve the right to make any changes according to technological progress or further developments.
The customer is not released from the obligation to conduct careful inspection and testing of incoming goods. Performance of the
product described herein should be verified by testing, which should be carried out only by qualified experts in the sole responsibility of
a customer. Reference to trade names used by other companies is neither a recommendation, nor does it imply that similar products
could not be used. (Status: April, 2008)
[email protected] www.evonik.com/personal-care